Cacco, Inc. (4166) AI Stock Analysis

• Market Cap: ¥1.92B
• Dividend Yield: N/A
• Average Volume (3M): 40.02K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.24
• Revenue Growth: 0.90%
• EPS Growth: 65.04%
• Country: JP
• Employees: 35
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): -11.85
• Shares Outstanding: 2,732,655
• 10 Day Avg. Volume: 11,830
• 30 Day Avg. Volume: 40,016
• PEG Ratio: 0.29
• Price to Book (P/B): 1.98
• Price to Sales (P/S): 2.24
• P/FCF Ratio: -8.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: ¥746.00 ▲(8.12% Upside)

Cacco, Inc. faces significant financial challenges with declining revenues and negative cash flows, heavily impacting its overall score. The technical analysis indicates a bearish trend, and the valuation is poor due to negative earnings. These factors contribute to a low overall stock score.

Cacco, Inc. Business Overview & Revenue Model

Company Description

Cacco, Inc. (4166) is a technology-driven company specializing in software solutions for the healthcare sector. The company develops innovative applications aimed at improving patient care and operational efficiency within hospitals and clinics. Cacco, Inc. offers a range of products, including electronic health record (EHR) systems, telemedicine platforms, and healthcare analytics tools that empower healthcare providers to enhance service delivery and patient outcomes.

How the Company Makes Money

Cacco, Inc. generates revenue primarily through the sale of its software products and subscription-based services. The company charges healthcare providers a licensing fee for its EHR systems, which typically includes installation, maintenance, and support services. Additionally, Cacco, Inc. earns recurring revenue from subscription fees associated with its telemedicine platform, where healthcare facilities pay monthly or annual fees based on usage. Key revenue streams also include revenue from consulting services and customized solutions for larger healthcare organizations. Strategic partnerships with major healthcare systems and technology firms further bolster its earnings by expanding its customer base and enhancing its product offerings.

Cacco, Inc. Financial Statement Overview

Summary

Cacco, Inc. is experiencing financial difficulties with declining revenues and profitability, as well as negative cash flows. Despite a strong equity position, the company faces operational challenges that impact its financial health.

Income Statement

Cacco, Inc. has experienced a significant decline in revenue and profitability. The gross profit margin has decreased from 67.8% in 2022 to 60.6% in 2024, and the net profit margin is negative, indicating losses. Revenue growth has been negative, with a 22.9% decline from 2023 to 2024. The company is also facing negative EBIT and EBITDA margins, reflecting operational challenges.

Balance Sheet

The balance sheet shows a strong equity position with an equity ratio of 81.2% in 2024, indicating financial stability. The debt-to-equity ratio is low at 0.1, suggesting low leverage. However, the return on equity has turned negative due to net losses, which is a concern for profitability.

Cash Flow

Cacco, Inc. is facing cash flow challenges with negative operating and free cash flows in 2024. The free cash flow to net income ratio is unfavorable, and the operating cash flow to net income ratio is negative, indicating inefficiencies in converting income to cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	793.43M	734.02M	952.00M	1.08B	951.14M	831.35M
Gross Profit	514.85M	445.02M	586.50M	729.95M	690.91M	587.78M
EBITDA	-132.73M	-211.00M	-215.67M	244.87M	191.91M	131.56M
Net Income	-170.32M	-255.03M	-320.00M	100.35M	120.31M	130.03M
Balance Sheet
Total Assets	996.00M	1.03B	1.29B	1.53B	1.42B	1.82B
Cash, Cash Equivalents and Short-Term Investments	684.00M	734.00M	941.00M	962.07M	800.65M	1.29B
Total Debt	98.00M	82.14M	96.00M	1.80M	6.08M	510.19M
Total Liabilities	210.00M	193.10M	214.00M	161.13M	143.98M	674.49M
Stockholders Equity	786.00M	832.17M	1.07B	1.37B	1.27B	1.15B
Cash Flow
Free Cash Flow	0.00	-200.00M	-56.00M	212.50M	21.94M	-3.94M
Operating Cash Flow	0.00	-198.00M	-49.31M	250.38M	149.66M	166.75M
Investing Cash Flow	0.00	-2.06M	-69.68M	-86.61M	-134.25M	-197.67M
Financing Cash Flow	0.00	-5.68M	98.01M	-2.34M	-507.94M	734.08M

Cacco, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 690.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4166, the sentiment is Negative. The current price of 690 is below the 20-day moving average (MA) of 718.70, below the 50-day MA of 766.82, and below the 200-day MA of 706.18, indicating a bearish trend. The MACD of -22.03 indicates Positive momentum. The RSI at 37.44 is Neutral, neither overbought nor oversold. The STOCH value of 16.72 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4166.

Cacco, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5256	75 Outperform	¥3.22B	16.55	―	―	8.55%	22.83%
5028	73 Outperform	¥3.44B	20.64	―	―	38.06%	507.02%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
4052	52 Neutral	¥1.87B	-48.50	―	―	0.69%	-386.26%
5577	52 Neutral	¥5.88B	-80.06	―	―	-4.84%	-161.59%
4199	51 Neutral	¥1.90B	-14.76	―	―	-5.47%	-239.04%
4166	42 Neutral	¥1.92B	-11.20	―	―	0.90%	65.04%

Cacco, Inc. Corporate Events

Cacco, Inc. Reports Improved Sales but Ongoing Losses in Q2 FY2025

Cacco, Inc. reported its financial results for the second quarter of fiscal year 2025, showing a significant improvement in net sales by 17.3% compared to the previous year, despite recording a net loss. The company has maintained a strong capital ratio of 78.9%, indicating a stable financial position, although it continues to face challenges in achieving profitability.

The most recent analyst rating on (JP:4166) stock is a Hold with a Yen842.00 price target. To see the full list of analyst forecasts on Cacco, Inc. stock, see the JP:4166 Stock Forecast page.